-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Omada Health, Lowers Price Target to $25

Benzinga·11/16/2026 18:31:33
Listen to the news
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $30 to $25.